Clinical implications of copy number variations on chromosome 16


Creative Commons License

Heidargholizadeh S., Karaman B., Kalaycı T., Aslanger A. D., Bulut G., Turgut G. T., ...Daha Fazla

European Human Genetics Conference, Berlin, Almanya, 1 - 04 Haziran 2024, ss.1

  • Yayın Türü: Bildiri / Tam Metin Bildiri
  • Basıldığı Şehir: Berlin
  • Basıldığı Ülke: Almanya
  • Sayfa Sayıları: ss.1
  • İstanbul Üniversitesi Adresli: Evet

Özet

Background: Segmental copies in chromosome 16 render the chromosome unstable and

predispose it to producing Copy Number Variations (CNVs). However incomplete penetrance

and diverse phenotypes, complicate prenatal genetic counseling. We analyzed the prenatal

ultrasound and postnatal phenotypic characteristics associated with chromosome 16 CNVs

to improve diagnosis and monitoring of this disease in the cases.

Methods: We screened cases that underwent karyotyping and CMA from 2008 to 2023. We

selected 37 cases with anomalies in chromosome 16, involving 19 prenatal and 18 postnatal

cases, and characterized their phenotypes based on medical records. Additionally, the type

and parental origin of these CNVs were determined.

Result: We detected 37 CNVs, including 15 microdeletions and 17 microduplications, and

five showed apparently balanced rearrangement with potential clinical significance. Of these

CNV’s, 20 were microdeletion/microduplication syndromes involving distinct genomic regions

previously defined as 16p13.11, 16p12.2, 16p11.2 and 16p13.3 microdeletions, as well as 16

p11.2-p12.2 and 16p11.2 microduplications. The remaining 17 CNVs are reported less

frequently and include 16p13.11p12.3 deletions/duplication, anomalies of the q arm of

chromosome 16, marker chromosome, balanced chromosomal rearrangements, and

complex chromosomal anomaly involving chromosome 16. Of these, 19 cases were verified

by pedigree, with 7/19 cases de novo and the rest being familial.

Conclusion: Our findings can contribute to the creation of a chromosome 16 disease map

based on regions that may be associated with disease development. The phenotypic

outcome cannot be predicted owing to the variable expressivity and incomplete penetrance

of these CNVs.